Natco Pharma has made a firm offer to acquire nearly 36% stake in South African drug firm Adcock Ingram Holdings for up to Rs 2,100 crore. This acquisition will provide Natco Pharma with a strong ...

Adcock Ingram posted revenue of about $536 million for the year through June 2024 and $262 million for the first half of FY25. Its EBITDA was $78 million for FY24 and $38 million for the six months ...

Adcock Ingram generated revenue of R6.9bn in the 2024 financial year. The company achieved EBITDA of R1.4bn, at a margin of 14.6%, and a profit after tax of R814m.

Natco Pharma plans to acquire South Africa-based Adcock Ingram Holdings, reported CNBC-Awaaz on July 23 citing sources. Adcock Ingram offers generics and OTC medicines in Africa.

Adcock Ingram surged the most on record after India’s Natco Pharma said it will acquire a stake in the South African drugmaker for about R4 billion. Hyderabad-based Natco is offering R75 per share for ...